theophylline has been researched along with Bacterial Disease in 21 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A total of 43 hospitalized adult patients with acute exacerbations of chronic bronchitis or bronchiectasis due to Gram-negative bacteria were randomized to receive either enoxacin (400 mg bd) or amoxycillin (1,000 mg tid) for 7-12 days." | 9.06 | Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin. ( Blogie, M; Carpiaux, JP; Glupczynski, Y; Prigogine, T; Schmerber, JS; Yourassowsky, E, 1988) |
| "Eighty hospital patients with acute purulent exacerbations of chronic bronchitis associated with Haemophilus influenzae, Streptococcus pneumoniae, Branhamella catarrhalis or Pseudomonas aeruginosa were treated with ciprofloxacin." | 7.67 | Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. ( Baur, C; Davies, BI; Maesen, FP, 1986) |
| "Ciprofloxacin was as effective as ampicillin and produced a 98 percent clinical cure rate." | 6.66 | Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections. ( Afzal, Q; Guarneri, JJ; Khan, FA; LaBombardi, V; Raoof, S; Wollschlager, CM, 1987) |
| "A total of 43 hospitalized adult patients with acute exacerbations of chronic bronchitis or bronchiectasis due to Gram-negative bacteria were randomized to receive either enoxacin (400 mg bd) or amoxycillin (1,000 mg tid) for 7-12 days." | 5.06 | Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin. ( Blogie, M; Carpiaux, JP; Glupczynski, Y; Prigogine, T; Schmerber, JS; Yourassowsky, E, 1988) |
| "Ofloxacin is a 4-quinolone antibiotic with rapid bactericidal activity against a wide variety of organisms." | 3.76 | Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application. ( Drew, RH; Gallis, HA, 1988) |
| "In order to determine the efficacy and safety of the new quinolone ofloxacin in the treatment of chronic lower respiratory disease, 674 patients (353 with chronic bronchitis, 212 with community-acquired pneumonia and 109 with hospital-acquired pneumonia) were treated with ofloxacin 200 mg twice a day." | 3.68 | Ofloxacin in lower respiratory tract infections. ( Petermann, W, 1991) |
| "Eighty hospital patients with acute purulent exacerbations of chronic bronchitis associated with Haemophilus influenzae, Streptococcus pneumoniae, Branhamella catarrhalis or Pseudomonas aeruginosa were treated with ciprofloxacin." | 3.67 | Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis. ( Baur, C; Davies, BI; Maesen, FP, 1986) |
| "Ciprofloxacin was as effective as ampicillin and produced a 98 percent clinical cure rate." | 2.66 | Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections. ( Afzal, Q; Guarneri, JJ; Khan, FA; LaBombardi, V; Raoof, S; Wollschlager, CM, 1987) |
| " Although they have been known to have various adverse effects, most of the mechanisms remain still unknown." | 2.47 | [Safety profile of antimicrobial agents]. ( Hori, S, 2011) |
| "The bronchial asthma is a polyetiologic syndrome with increased bronchomotoric excitability." | 2.36 | [New viewpoints in the pathogenesis and therapy of bronchial asthma]. ( Jäger, L, 1979) |
| "Exacerbations in COPD patients are characterized by an acute aggravation of the condition with an increase in symptoms (labored breathing, cough, expectoration, tightness of the chest and, rarely, fever)." | 1.33 | [COPD--how to deal with an acute exacerbation]. ( Worth, H, 2006) |
| "Urticaria was observed in one of the patients as an adverse reaction to the drug, while abnormal laboratory test results were noted in 3 patients, but none of such changes were severe." | 1.27 | [Clinical results of a rokitamycin dry syrup in pediatric infections]. ( Asuka, T; Kawauchi, K; Kimura, S; Okamoto, T; Onishi, A; Sato, Y; Takebe, Y; Tsushima, T; Yokoyama, M; Yonesaka, S, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (52.38) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rademacher, J | 1 |
| Welte, T | 1 |
| Hori, S | 1 |
| Devillier, P | 1 |
| Worth, H | 1 |
| Singh, A | 2 |
| Barr, PA | 1 |
| O'Loughlin, EV | 1 |
| Anderson, DG | 1 |
| Sherk, PA | 1 |
| Grossman, RF | 1 |
| Adanin, S | 1 |
| Yalovetskiy, IV | 1 |
| Nardulli, BA | 1 |
| Sam, AD | 1 |
| Jonjev, ZS | 1 |
| Law, WR | 1 |
| Jäger, L | 1 |
| Lertzman, MM | 1 |
| Cherniack, RM | 1 |
| Hopkins, S | 1 |
| Petermann, W | 1 |
| Berezhinskaia, VV | 1 |
| Dolgova, GV | 1 |
| Davies, BI | 2 |
| Maesen, FP | 2 |
| Baur, C | 2 |
| Prigogine, T | 1 |
| Glupczynski, Y | 1 |
| Carpiaux, JP | 1 |
| Blogie, M | 1 |
| Yourassowsky, E | 1 |
| Schmerber, JS | 1 |
| Kawauchi, K | 1 |
| Sato, Y | 1 |
| Kimura, S | 1 |
| Yonesaka, S | 1 |
| Yokoyama, M | 1 |
| Onishi, A | 1 |
| Asuka, T | 1 |
| Okamoto, T | 1 |
| Takebe, Y | 1 |
| Tsushima, T | 1 |
| Drew, RH | 1 |
| Gallis, HA | 1 |
| Sumajow, CA | 1 |
| Wollschlager, CM | 1 |
| Raoof, S | 1 |
| Khan, FA | 1 |
| Guarneri, JJ | 1 |
| LaBombardi, V | 1 |
| Afzal, Q | 1 |
| Dobrowolski, LA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes: A Randomized Controlled Trial[NCT05328817] | 240 participants (Anticipated) | Interventional | 2022-05-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for theophylline and Bacterial Disease
| Article | Year |
|---|---|
[New antibiotics - standstill or progress].
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftaroline; Ceftazidime; Cephalo | 2017 |
[Safety profile of antimicrobial agents].
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Infections; Convu | 2011 |
[Physiopathology of COPD: choosing the right therapeutic targets].
Topics: Adrenal Cortex Hormones; Aged; Albuterol; Animals; Bacterial Infections; Bronchodilator Agents; Carb | 2003 |
The chronic obstructive pulmonary disease exacerbation.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Bacterial Infections; Bronchodilator Agents; Dietary | 2000 |
[New viewpoints in the pathogenesis and therapy of bronchial asthma].
Topics: Acetylcholine; Adrenergic beta-Agonists; Analgesics; Asthma; Atropine; Bacterial Infections; Bronchi | 1979 |
[Macrolide antibiotics and their use in combined pharmacotherapy].
Topics: Bacterial Infections; Depression, Chemical; Drug Interactions; Drug Therapy, Combination; Erythromyc | 1989 |
Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Int | 1988 |
5 trials available for theophylline and Bacterial Disease
| Article | Year |
|---|---|
Clinical toleration and safety of azithromycin.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Carbama | 1991 |
Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacterial Infecti | 1988 |
Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.
Topics: Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Int | 1988 |
Clinical, microbiological and pharmacokinetic studies on ofloxacin in acute purulent exacerbations of chronic respiratory disease.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Chronic Disease; Drug Therapy, Combination; Fe | 1986 |
Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Ciprofloxacin; Clinical Trials as | 1987 |
10 other studies available for theophylline and Bacterial Disease
| Article | Year |
|---|---|
[COPD--how to deal with an acute exacerbation].
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Bacterial Agents; Bacterial Infections; Bronchodilator | 2006 |
Beyond the "ABC approach".
Topics: Acute Disease; Bacterial Infections; Biomarkers; C-Reactive Protein; Humans; Hypoxia; Inflammation; | 2007 |
On treating and preventing acute exacerbations in COPD.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Bacterial Infections; Bronchodilator Agents; Humans; | 2008 |
Bacterial infection in preterm infants during xanthine therapy for idiopathic apnoea of prematurity.
Topics: Aminophylline; Apnea; Bacterial Infections; Female; Humans; Infant, Newborn; Infant, Premature, Dise | 1980 |
Inhibiting adenosine deaminase modulates the systemic inflammatory response syndrome in endotoxemia and sepsis.
Topics: Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Bacterial Infections; Blood; Chronic D | 2002 |
Rehabilitation of patients with chronic obstructive pulmonary disease.
Topics: Adrenal Cortex Hormones; Airway Resistance; Atropine; Bacterial Infections; Follow-Up Studies; Healt | 1976 |
Ofloxacin in lower respiratory tract infections.
Topics: Bacterial Infections; Bronchitis; Chronic Disease; Cross Infection; Drug Administration Schedule; Dr | 1991 |
Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxacin; Drug | 1986 |
[Clinical results of a rokitamycin dry syrup in pediatric infections].
Topics: Acute Disease; Administration, Oral; Bacterial Infections; Child; Child, Preschool; Drug Evaluation; | 1988 |
[Treatment of the bronchitic syndrome associated with bacterial infection].
Topics: Adult; Aged; Bacterial Infections; Bronchitis; Codeine; Ethylamines; Guaifenesin; Humans; Middle Age | 1972 |